Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arian Lasocki

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Medical Imaging and Radiation Oncology|November 25, 2015
Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastomaArian Lasocki, Frank Gaillard, Mark Tacey, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 26, 2016
Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implicationsArian Lasocki, Frank Gaillard, Mark Tacey, et al.
Neuroradiology|August 26, 2020
Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic reviewArian Lasocki, Mustafa Anjari, Suna Ӧrs Kokurcan, et al.
AJNR. American Journal of Neuroradiology|October 26, 2023
Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q DeletionArian Lasocki, Michael E Buckland, Tahlia Molinaro, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 19, 2017
Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastomaArian Lasocki, Alpha Tsui, Frank Gaillard, et al.
AJNR. American Journal of Neuroradiology|August 24, 2023
Prospective Comparison of T1-SPACE and MPRAGE for the Identification of Intrinsic T1 Hyperintensity in Patients with Intracranial Melanoma MetastasesArian Lasocki, Stephen L Stuckey, Lauren Caspersz, et al.
Journal of Medical Imaging and Radiation Oncology|January 18, 2023
Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgeryLorenztino Admojo, James Korte, Nigel Anderson, et al.
Neuroradiology|April 3, 2021
The role of 2-hydroxyglutarate magnetic resonance spectroscopy for the determination of isocitrate dehydrogenase status in lower grade gliomas versus glioblastoma: a systematic review and meta-analysis of diagnostic test accuracyAbhishta Bhandari, Chinmay Sharma, Muhammad Ibrahim, et al.
Journal of Neuro-Oncology|July 15, 2016
The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastomaArian Lasocki, Frank Gaillard, Mark A Tacey, et al.
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Relative efficacy of different MRI signs in diagnosing active Crohn's disease, compared against a histological gold standardArian Lasocki, Alexander Pitman, Richard Williams, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Medical Imaging and Radiation Oncology|November 25, 2015
Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastomaArian Lasocki, Frank Gaillard, Mark Tacey, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 26, 2016
Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implicationsArian Lasocki, Frank Gaillard, Mark Tacey, et al.
Neuroradiology|August 26, 2020
Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic reviewArian Lasocki, Mustafa Anjari, Suna Ӧrs Kokurcan, et al.
AJNR. American Journal of Neuroradiology|October 26, 2023
Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q DeletionArian Lasocki, Michael E Buckland, Tahlia Molinaro, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 19, 2017
Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastomaArian Lasocki, Alpha Tsui, Frank Gaillard, et al.
AJNR. American Journal of Neuroradiology|August 24, 2023
Prospective Comparison of T1-SPACE and MPRAGE for the Identification of Intrinsic T1 Hyperintensity in Patients with Intracranial Melanoma MetastasesArian Lasocki, Stephen L Stuckey, Lauren Caspersz, et al.
Journal of Medical Imaging and Radiation Oncology|January 18, 2023
Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgeryLorenztino Admojo, James Korte, Nigel Anderson, et al.
Neuroradiology|April 3, 2021
The role of 2-hydroxyglutarate magnetic resonance spectroscopy for the determination of isocitrate dehydrogenase status in lower grade gliomas versus glioblastoma: a systematic review and meta-analysis of diagnostic test accuracyAbhishta Bhandari, Chinmay Sharma, Muhammad Ibrahim, et al.
Journal of Neuro-Oncology|July 15, 2016
The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastomaArian Lasocki, Frank Gaillard, Mark A Tacey, et al.
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Relative efficacy of different MRI signs in diagnosing active Crohn's disease, compared against a histological gold standardArian Lasocki, Alexander Pitman, Richard Williams, et al.
Pageof 6